REFERENCES
  1. A Yassine, I., M Eldeeb, W., A Gad, K., A Ashour, Y., A Yassine, I., & O Hosny, A. (2018). Cognitive functions, electroencephalographic and diffusion tensor imaging changes in children with active idiopathic epilepsy. Epilepsy & Behavior: E&B , 84 , 135–141. https://doi.org/10.1016/j.yebeh.2018.04.024
  2. Abou-Khalil, B. W. (2016). Antiepileptic Drugs. Continuum (Minneapolis, Minn.) , 22 (1 Epilepsy), 132–156. https://doi.org/10.1212/CON.0000000000000289
  3. Adedapo, A. D. A., Adedeji, W. A., Adedapo, I. A., & Adedapo, K. S. (2021). Cohort study on adverse drug reactions in adults admitted to the medical wards of a tertiary hospital in Nigeria: Prevalence, incidence, risk factors and fatality. British Journal of Clinical Pharmacology , 87 (4), 1878–1889. https://doi.org/10.1111/bcp.14577
  4. Adeloye, D. (2014). An estimate of the incidence and prevalence of stroke in Africa: A systematic review and meta-analysis. PloS One , 9 (6), e100724. https://doi.org/10.1371/journal.pone.0100724
  5. Assadeck, H., Toudou Daouda, M., Moussa Konate, M., Mamadou, Z., Hassane Djibo, F., Douma Maiga, D., & Sanoussi, S. (2019). Clinical and etiological characteristics of epilepsy in people from Niger: A hospital-based study from a tertiary care referral center of Niamey, Niger. Epilepsia Open , 4 (2), 318–327. https://doi.org/10.1002/epi4.12325
  6. Bates, D. W., Cullen, D. J., Laird, N., Petersen, L. A., Small, S. D., Servi, D., Laffel, G., Sweitzer, B. J., Shea, B. F., & Hallisey, R. (1995). Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group.JAMA , 274 (1), 29–34.
  7. Belcastro, V., Costa, C., Galletti, F., Autuori, A., Pierguidi, L., Pisani, F., Calabresi, P., & Parnetti, L. (2008). Levetiracetam in newly diagnosed late-onset post-stroke seizures: A prospective observational study. Epilepsy Research , 82 (2–3), 223–226. https://doi.org/10.1016/j.eplepsyres.2008.08.008
  8. Brodie, M. J., & Sills, G. J. (2011). Combining antiepileptic drugs—Rational polytherapy? Seizure , 20 (5), 369–375. https://doi.org/10.1016/j.seizure.2011.01.004
  9. Brodie, M. J., Zuberi, S. M., Scheffer, I. E., & Fisher, R. S. (2018). The 2017 ILAE classification of seizure types and the epilepsies: What do people with epilepsy and their caregivers need to know? Epileptic Disorders: International Epilepsy Journal with Videotape , 20 (2), 77–87. https://doi.org/10.1684/epd.2018.0957
  10. Coleman, J. J., & Pontefract, S. K. (2016). Adverse drug reactions.Clinical Medicine , 16 (5), 481–485. https://doi.org/10.7861/clinmedicine.16-5-481
  11. Ding, D., Zhou, D., Sander, J. W., Wang, W., Li, S., & Hong, Z. (2021). Epilepsy in China: Major progress in the past two decades.The Lancet. Neurology , 20 (4), 316–326. https://doi.org/10.1016/S1474-4422(21)00023-5
  12. Du, Y., Lin, J., Shen, J., Ding, S., Ye, M., Wang, L., Wang, Y., Wang, X., Xia, N., Zheng, R., Chen, H., & Xu, H. (2019). Adverse drug reactions associated with six commonly used antiepileptic drugs in southern China from 2003 to 2015. BMC Pharmacology and Toxicology , 20 (1), 7. https://doi.org/10.1186/s40360-019-0285-y
  13. Fadare, J. O., Sunmonu, T. A., Bankole, I. A., Adekeye, K. A., & Abubakar, S. A. (2018). Medication adherence and adverse effect profile of antiepileptic drugs in Nigerian patients with epilepsy.Neurodegenerative Disease Management , 8 (1), 25–36. https://doi.org/10.2217/nmt-2017-0044
  14. Fisher, R. S. (2017). An overview of the 2017 ILAE operational classification of seizure types. Epilepsy & Behavior: E&B ,70 (Pt A), 271–273. https://doi.org/10.1016/j.yebeh.2017.03.022
  15. George, J., Kulkarni, C., & Sarma, G. R. K. (2015). Antiepileptic Drugs and Quality of Life in Patients with Epilepsy: A Tertiary Care Hospital-Based Study. Value in Health Regional Issues ,6 , 1–6. https://doi.org/10.1016/j.vhri.2014.07.009
  16. Goodman, N. F., Cobin, R. H., Futterweit, W., Glueck, J. S., Legro, R. S., Carmina, E., American Association of Clinical Endocrinologists (AACE), American College of Endocrinology (ACE), & Androgen Excess and PCOS Society. (2015). AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 2. Endocrine Practice: Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists , 21 (12), 1415–1426. https://doi.org/10.4158/EP15748.DSCPT2
  17. Habib, M., Khan, S. U., Hoque, M. A., Mondal, M. B. A., Hasan, A. H., Chowdhury, R. N., Haque, B., Rahman, K. M., Chowdhury, A. H., Ghose, S. K., & Mohammad, Q. D. (2013). Antiepileptic drug utilization in Bangladesh: Experience from Dhaka Medical College Hospital. BMC Research Notes , 6 , 473. https://doi.org/10.1186/1756-0500-6-473
  18. Hirsch, L. J., LaRoche, S. M., Gaspard, N., Gerard, E., Svoronos, A., Herman, S. T., Mani, R., Arif, H., Jette, N., Minazad, Y., Kerrigan, J. F., Vespa, P., Hantus, S., Claassen, J., Young, G. B., So, E., Kaplan, P. W., Nuwer, M. R., Fountain, N. B., & Drislane, F. W. (2013). American Clinical Neurophysiology Society’s Standardized Critical Care EEG Terminology: 2012 version. Journal of Clinical Neurophysiology: Official Publication of the American Electroencephalographic Society , 30 (1), 1–27. https://doi.org/10.1097/WNP.0b013e3182784729
  19. Joshi, R., Tripathi, M., Gupta, P., Gulati, S., & Gupta, Y. K. (2017). Adverse effects & drug load of antiepileptic drugs in patients with epilepsy: Monotherapy versus polytherapy. The Indian Journal of Medical Research , 145 (3), 317–326. https://doi.org/10.4103/ijmr.IJMR_710_15
  20. Kaushik, S., Chopra, D., Sharma, S., & Aneja, S. (2019). Adverse Drug Reactions of Anti-Epileptic Drugs in Children with Epilepsy: A Cross-Sectional Study. Current Drug Safety , 14 (3), 217–224. https://doi.org/10.2174/1574886314666190311112710
  21. Lee, S.-J., Kim, J.-E., Seo, J.-G., Cho, Y. W., Lee, J.-J., Moon, H.-J., & Park, S.-P. (2014). Predictors of quality of life and their interrelations in Korean people with epilepsy: A MEPSY study.Seizure , 23 (9), 762–768. https://doi.org/10.1016/j.seizure.2014.06.007
  22. Lyseng-Williamson, K. A. (2011). Levetiracetam: A review of its use in epilepsy. Drugs , 71 (4), 489–514. https://doi.org/10.2165/11204490-000000000-00000
  23. Meador, K. J., Penovich, P., Baker, G. A., Pennell, P. B., Bromfield, E., Pack, A., Liporace, J. D., Sam, M., Kalayjian, L. A., Thurman, D. J., Moore, E., Loring, D. W., & NEAD Study Group. (2009). Antiepileptic drug use in women of childbearing age. Epilepsy & Behavior: E&B , 15 (3), 339–343. https://doi.org/10.1016/j.yebeh.2009.04.026
  24. Nwani, P. O., Nwosu, M. C., Enwereji, K. O., Asomugha, A. L., Arinzechi, E. O., & Ogunniyi, A. O. (2013). Epilepsy treatment gap: Prevalence and associated factors in Southeast Nigeria. Acta Neurologica Scandinavica , 128 (2), 83–90. https://doi.org/10.1111/ane.12096
  25. Olusanya, A., Ogunleye, O., Godman, B., Fadare, J., & Danesi, M. (2017). Adverse effects of carbamazepine monotherapy among patients in Nigeria: A pilot study and implications. Journal of Comparative Effectiveness Research , 6 (1), 33–42. https://doi.org/10.2217/cer-2016-0057
  26. Owolabi, L. F., Owolabi, S. D., Adamu, B., Jibo, A. M., & Alhaji, I. D. (2020). Epilepsy treatment gap in Sub-Saharan Africa: Meta-analysis of community-based studies. Acta Neurologica Scandinavica ,142 (1), 3–13. https://doi.org/10.1111/ane.13246
  27. Paul, A., Adeloye, D., George-Carey, R., Kolčić, I., Grant, L., & Chan, K. Y. (2012). An estimate of the prevalence of epilepsy in Sub-Saharan Africa: A systematic analysis. Journal of Global Health , 2 (2), 020405. https://doi.org/10.7189/jogh.02.020405
  28. Roy, S., Goud, N. R., & Matzger, A. J. (2016). Polymorphism in phenobarbital: Discovery of a new polymorph and crystal structure of elusive form V. Chemical Communications (Cambridge, England) ,52 (23), 4389–4392. https://doi.org/10.1039/c6cc00959j
  29. Sakuma, M., Ida, H., Nakamura, T., Ohta, Y., Yamamoto, K., Seki, S., Hiroi, K., Kikuchi, K., Nakayama, K., Bates, D. W., & Morimoto, T. (2014). Adverse drug events and medication errors in Japanese paediatric inpatients: A retrospective cohort study. BMJ Quality & Safety , 23 (10), 830–837. https://doi.org/10.1136/bmjqs-2013-002658
  30. Scheffer, I. E., Berkovic, S., Capovilla, G., Connolly, M. B., French, J., Guilhoto, L., Hirsch, E., Jain, S., Mathern, G. W., Moshé, S. L., Nordli, D. R., Perucca, E., Tomson, T., Wiebe, S., Zhang, Y.-H., & Zuberi, S. M. (2017). ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology.Epilepsia , 58 (4), 512–521. https://doi.org/10.1111/epi.13709
  31. Silvennoinen, K., de Lange, N., Zagaglia, S., Balestrini, S., Androsova, G., Wassenaar, M., Auce, P., Avbersek, A., Becker, F., Berghuis, B., Campbell, E., Coppola, A., Francis, B., Wolking, S., Cavalleri, G. L., Craig, J., Delanty, N., Johnson, M. R., Koeleman, B. P. C., … EpiPGX Consortium. (2019). Comparative effectiveness of antiepileptic drugs in juvenile myoclonic epilepsy. Epilepsia Open , 4 (3), 420–430. https://doi.org/10.1002/epi4.12349
  32. St. Louis, E. (2009). Minimizing AED Adverse Effects: Improving Quality of Life in the Interictal State in Epilepsy Care.Current Neuropharmacology , 7 (2), 106–114. https://doi.org/10.2174/157015909788848857
  33. Stephen, L. J., & Brodie, M. J. (2012). Antiepileptic drug monotherapy versus polytherapy: Pursuing seizure freedom and tolerability in adults. Current Opinion in Neurology ,25 (2), 164–172. https://doi.org/10.1097/WCO.0b013e328350ba68
  34. Yang, A., Wang, B., Zhu, G., Jiao, Z., Fang, Y., Tang, F., Ma, C., Zhao, Y., Cheng, C., & Zhong, M. (2014). Validation of Chinese version of the Morisky medication adherence scale in patients with epilepsy. Seizure , 23 (4), 295–299. https://doi.org/10.1016/j.seizure.2014.01.003